Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2026 Earnings Call Transcript May 4, 2026
Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $1.83, expectations were $1.45.
Operator: Thank you for standing by, and welcome to the Krystal Biotech First Quarter 2026 Conference Call. [Operator Instructions] As a reminder, today’s conference is being recorded. I would now like to hand the conference over to your host, Stephane Paquette, Vice President of Corporate Development. Please...
